Global IgM/IgG Rapid Test Kits Market

IgM/IgG Rapid Test Kits Comprehensive Study by Type (RDT(Rapid Diagnostic Test), ELISA(Enzyme-linked Immunosorbent Assay), Neutralization Assay), Application (Hospital, Special Clinic, Research Institution), Kit Components (Detection Cassette, Sample Diluent, Lancet, Bandage, Others), Sample Types (Blood, Serum, Plasma, Others) Players and Region - Global Market Outlook to 2030

IgM/IgG Rapid Test Kits Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 20.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is IgM/IgG Rapid Test Kits?
The Rapid COVID-19 IgM / IgG Combo Test Kit is a lateral flow immunoassay for the purpose of qualitative detection as well as differentiation of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies that work against SARS-CoV-2 in human serum and acid citrate dextrose (ACD) )) Plasma. The global market for corona test kits is growing rapidly due to the global outbreak of the coronavirus. The number of patients in hospitals is growing rapidly and these countries are trying to get access to the test kit to screen every suspect and slow the spread of the virus. BioMedomics' combined IgM-IgG rapid test for COVID-19 is a lateral flow immunoassay that can be used to qualitatively detect IgG and IgM antibodies of the new coronavirus in human serum, plasma, or whole blood in vitro. The test should not be used with heat-inactivated or any other inactivated human specimens such as blood, serum, plasma, etc. Fresh samples should be collected and tested immediately. The combo test kit is usually used for identifying individuals with an adaptive immune response to SARS-CoV-2 who indicate a recent or previous infection. At this point, it is unknown how long antibodies persist after infection and whether the presence of antibodies confers protective immunity. The IgM / IgG Combo Test Kit is not be used for diagnosing acute SARS-CoV-2 infection. The tests are limited to laboratories that are certified according to the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42, USA, 263a, and meet the requirements for performing tests of medium or high complexity. The fast COVID-19 IgM / IgG combination test kit is based on the principle of immunochromatography. Mouse anti-human IgM and human IgG antibodies are immobilized on the nitrocellulose membrane as two individual test lines (IgM line and IgG line) in the test window of the test device. The IgM line in the test window is closer to the sample well, followed by the IgG line. While the test sample flows through the membrane.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledCellex (Germany), RayBiotech (United States), Biopanda (United Kingdom), BioMedomics (United States), GenBody(South Korea), SD Biosensor(South Korea), Advaite (United States), Premier Biotech (United States), Epitope Diagnostics (United States), CTK Biotech (United States), Creative Diagnostics (United States), Eagle Biosciences (United States), Sure Biotech (United States), SugenTech Inc. (South Korea), Sensing Self, PTE. Ltd (Singapore), Euroimmun AG (Germany), Liming Bio (China), Beijing Wantai Biological (China) and Livzon Diagnostics (China)
CAGR20.3%


The study covers a detailed analysis segmented by key business segments i.e. by type (RDT(Rapid Diagnostic Test), ELISA(Enzyme-linked Immunosorbent Assay) and Neutralization Assay) , by application (Hospital, Special Clinic and Research Institution) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global IgM/IgG Rapid Test Kits market throughout the predicted period.

The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this IgM/IgG Rapid Test Kits market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, some of them are Cellex (Germany), RayBiotech (United States), Biopanda (United Kingdom), BioMedomics (United States), GenBody(South Korea), SD Biosensor(South Korea), Advaite (United States), Premier Biotech (United States), Epitope Diagnostics (United States), CTK Biotech (United States), Creative Diagnostics (United States), Eagle Biosciences (United States), Sure Biotech (United States), SugenTech Inc. (South Korea), Sensing Self, PTE. Ltd (Singapore), Euroimmun AG (Germany), Liming Bio (China), Beijing Wantai Biological (China) and Livzon Diagnostics (China).

Market Overview:
In August 2020, SSI Diagnostica acquires the American company CTK Biotech, which developed one of the worlds most precise Covid-19 antibody tests. The purchase expands our product portfolio and strengthens our global production and distribution network including access to new markets worldwide.
“Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised) - Immediately in Effect Guidance for Clinical Laboratories, Commercial Manufacturers, and Food and Drug Administration Staff.” “This policy is intended to remain in effect only for the duration of the public health emergency related to COVID-19 declared by the Secretary of Health and Human Services (HHS) on January 31, 2020, effective January 27, 2020, including any renewals made by the HHS Secretary in accordance with section 319(a)(2) of the Public Health Service Act (PHS Act).”
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies.

Influencing Trend:
Increasing Number of Investments for Research & Development of IgM/IgG Rapid Test Kits, Increasing Government and Industry Players Initiatives and Increasing Number of Laboratory to Check Diseases

Market Growth Drivers:
Increasing Demand for Corona Test Kits in Hospitals to Diagnose the Patients with Symptoms, Increasing Prevalence of Chronic Diseases and The Opening of Coronavirus Test Centers at Different Parts of Countries Across the World

Challenges:
Shortage of Corona Test Kits

Restraints:
Lack of WorkForce for Manufacturing of Test Kits and Stringent Government Policies about the Kits

Opportunities:
The number of patients in the hospitals is increasing rapidly, and the countries are trying to get access to the test kit to inspect each and every suspected person to slow the spread of the virus.

Key highlights of the Global IgM/IgG Rapid Test Kits market Study:
• CAGR of the market during the forecast period 2023-2030
• In-depth information on growth factors that will accelerate the IgM/IgG Rapid Test Kits market in next few years.
• Detailed Insights on futuristic trends and changing consumer behavior
• Forecast of the Global IgM/IgG Rapid Test Kits market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of IgM/IgG Rapid Test Kits Players

Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global IgM/IgG Rapid Test Kits market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in IgM/IgG Rapid Test Kits market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, and Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.

Report Objectives / Segmentation Covered

By Type
  • RDT(Rapid Diagnostic Test)
  • ELISA(Enzyme-linked Immunosorbent Assay)
  • Neutralization Assay
By Application
  • Hospital
  • Special Clinic
  • Research Institution
By Kit Components
  • Detection Cassette
  • Sample Diluent
  • Lancet
  • Bandage
  • Others

By Sample Types
  • Blood
  • Serum
  • Plasma
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Corona Test Kits in Hospitals to Diagnose the Patients with Symptoms
      • 3.2.2. Increasing Prevalence of Chronic Diseases
      • 3.2.3. The Opening of Coronavirus Test Centers at Different Parts of Countries Across the World
    • 3.3. Market Challenges
      • 3.3.1. Shortage of Corona Test Kits
    • 3.4. Market Trends
      • 3.4.1. Increasing Number of Investments for Research & Development of IgM/IgG Rapid Test Kits
      • 3.4.2. Increasing Government and Industry Players Initiatives
      • 3.4.3. Increasing Number of Laboratory to Check Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global IgM/IgG Rapid Test Kits, by Type, Application, Kit Components, Sample Types and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global IgM/IgG Rapid Test Kits (Value)
      • 5.2.1. Global IgM/IgG Rapid Test Kits by: Type (Value)
        • 5.2.1.1. RDT(Rapid Diagnostic Test)
        • 5.2.1.2. ELISA(Enzyme-linked Immunosorbent Assay)
        • 5.2.1.3. Neutralization Assay
      • 5.2.2. Global IgM/IgG Rapid Test Kits by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Special Clinic
        • 5.2.2.3. Research Institution
      • 5.2.3. Global IgM/IgG Rapid Test Kits by: Kit Components (Value)
        • 5.2.3.1. Detection Cassette
        • 5.2.3.2. Sample Diluent
        • 5.2.3.3. Lancet
        • 5.2.3.4. Bandage
        • 5.2.3.5. Others
      • 5.2.4. Global IgM/IgG Rapid Test Kits by: Sample Types (Value)
        • 5.2.4.1. Blood
        • 5.2.4.2. Serum
        • 5.2.4.3. Plasma
        • 5.2.4.4. Others
      • 5.2.5. Global IgM/IgG Rapid Test Kits Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. IgM/IgG Rapid Test Kits: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cellex (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. RayBiotech (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biopanda (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BioMedomics (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GenBody(South Korea)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. SD Biosensor(South Korea)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Advaite (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Premier Biotech (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Epitope Diagnostics (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. CTK Biotech (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Creative Diagnostics (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Eagle Biosciences (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Sure Biotech (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. SugenTech Inc. (South Korea)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Sensing Self, PTE. Ltd (Singapore)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Euroimmun AG (Germany)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Liming Bio (China)
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
      • 6.4.18. Beijing Wantai Biological (China)
        • 6.4.18.1. Business Overview
        • 6.4.18.2. Products/Services Offerings
        • 6.4.18.3. Financial Analysis
        • 6.4.18.4. SWOT Analysis
      • 6.4.19. Livzon Diagnostics (China)
        • 6.4.19.1. Business Overview
        • 6.4.19.2. Products/Services Offerings
        • 6.4.19.3. Financial Analysis
        • 6.4.19.4. SWOT Analysis
  • 7. Global IgM/IgG Rapid Test Kits Sale, by Type, Application, Kit Components, Sample Types and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global IgM/IgG Rapid Test Kits (Value)
      • 7.2.1. Global IgM/IgG Rapid Test Kits by: Type (Value)
        • 7.2.1.1. RDT(Rapid Diagnostic Test)
        • 7.2.1.2. ELISA(Enzyme-linked Immunosorbent Assay)
        • 7.2.1.3. Neutralization Assay
      • 7.2.2. Global IgM/IgG Rapid Test Kits by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Special Clinic
        • 7.2.2.3. Research Institution
      • 7.2.3. Global IgM/IgG Rapid Test Kits by: Kit Components (Value)
        • 7.2.3.1. Detection Cassette
        • 7.2.3.2. Sample Diluent
        • 7.2.3.3. Lancet
        • 7.2.3.4. Bandage
        • 7.2.3.5. Others
      • 7.2.4. Global IgM/IgG Rapid Test Kits by: Sample Types (Value)
        • 7.2.4.1. Blood
        • 7.2.4.2. Serum
        • 7.2.4.3. Plasma
        • 7.2.4.4. Others
      • 7.2.5. Global IgM/IgG Rapid Test Kits Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. IgM/IgG Rapid Test Kits: by Type(USD Million)
  • Table 2. IgM/IgG Rapid Test Kits RDT(Rapid Diagnostic Test) , by Region USD Million (2018-2023)
  • Table 3. IgM/IgG Rapid Test Kits ELISA(Enzyme-linked Immunosorbent Assay) , by Region USD Million (2018-2023)
  • Table 4. IgM/IgG Rapid Test Kits Neutralization Assay , by Region USD Million (2018-2023)
  • Table 5. IgM/IgG Rapid Test Kits: by Application(USD Million)
  • Table 6. IgM/IgG Rapid Test Kits Hospital , by Region USD Million (2018-2023)
  • Table 7. IgM/IgG Rapid Test Kits Special Clinic , by Region USD Million (2018-2023)
  • Table 8. IgM/IgG Rapid Test Kits Research Institution , by Region USD Million (2018-2023)
  • Table 9. IgM/IgG Rapid Test Kits: by Kit Components(USD Million)
  • Table 10. IgM/IgG Rapid Test Kits Detection Cassette , by Region USD Million (2018-2023)
  • Table 11. IgM/IgG Rapid Test Kits Sample Diluent , by Region USD Million (2018-2023)
  • Table 12. IgM/IgG Rapid Test Kits Lancet , by Region USD Million (2018-2023)
  • Table 13. IgM/IgG Rapid Test Kits Bandage , by Region USD Million (2018-2023)
  • Table 14. IgM/IgG Rapid Test Kits Others , by Region USD Million (2018-2023)
  • Table 15. IgM/IgG Rapid Test Kits: by Sample Types(USD Million)
  • Table 16. IgM/IgG Rapid Test Kits Blood , by Region USD Million (2018-2023)
  • Table 17. IgM/IgG Rapid Test Kits Serum , by Region USD Million (2018-2023)
  • Table 18. IgM/IgG Rapid Test Kits Plasma , by Region USD Million (2018-2023)
  • Table 19. IgM/IgG Rapid Test Kits Others , by Region USD Million (2018-2023)
  • Table 20. South America IgM/IgG Rapid Test Kits, by Country USD Million (2018-2023)
  • Table 21. South America IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 22. South America IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 23. South America IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 24. South America IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 25. Brazil IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 26. Brazil IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 27. Brazil IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 28. Brazil IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 29. Argentina IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 30. Argentina IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 31. Argentina IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 32. Argentina IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 33. Rest of South America IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 34. Rest of South America IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 35. Rest of South America IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 36. Rest of South America IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 37. Asia Pacific IgM/IgG Rapid Test Kits, by Country USD Million (2018-2023)
  • Table 38. Asia Pacific IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 39. Asia Pacific IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 40. Asia Pacific IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 41. Asia Pacific IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 42. China IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 43. China IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 44. China IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 45. China IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 46. Japan IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 47. Japan IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 48. Japan IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 49. Japan IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 50. India IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 51. India IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 52. India IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 53. India IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 54. South Korea IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 55. South Korea IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 56. South Korea IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 57. South Korea IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 58. Taiwan IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 59. Taiwan IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 60. Taiwan IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 61. Taiwan IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 62. Australia IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 63. Australia IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 64. Australia IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 65. Australia IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 70. Europe IgM/IgG Rapid Test Kits, by Country USD Million (2018-2023)
  • Table 71. Europe IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 72. Europe IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 73. Europe IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 74. Europe IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 75. Germany IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 76. Germany IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 77. Germany IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 78. Germany IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 79. France IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 80. France IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 81. France IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 82. France IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 83. Italy IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 84. Italy IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 85. Italy IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 86. Italy IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 87. United Kingdom IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 88. United Kingdom IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 89. United Kingdom IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 90. United Kingdom IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 91. Netherlands IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 92. Netherlands IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 93. Netherlands IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 94. Netherlands IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 95. Rest of Europe IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 96. Rest of Europe IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 97. Rest of Europe IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 98. Rest of Europe IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 99. MEA IgM/IgG Rapid Test Kits, by Country USD Million (2018-2023)
  • Table 100. MEA IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 101. MEA IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 102. MEA IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 103. MEA IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 104. Middle East IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 105. Middle East IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 106. Middle East IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 107. Middle East IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 108. Africa IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 109. Africa IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 110. Africa IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 111. Africa IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 112. North America IgM/IgG Rapid Test Kits, by Country USD Million (2018-2023)
  • Table 113. North America IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 114. North America IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 115. North America IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 116. North America IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 117. United States IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 118. United States IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 119. United States IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 120. United States IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 121. Canada IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 122. Canada IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 123. Canada IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 124. Canada IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 125. Mexico IgM/IgG Rapid Test Kits, by Type USD Million (2018-2023)
  • Table 126. Mexico IgM/IgG Rapid Test Kits, by Application USD Million (2018-2023)
  • Table 127. Mexico IgM/IgG Rapid Test Kits, by Kit Components USD Million (2018-2023)
  • Table 128. Mexico IgM/IgG Rapid Test Kits, by Sample Types USD Million (2018-2023)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. IgM/IgG Rapid Test Kits: by Type(USD Million)
  • Table 149. IgM/IgG Rapid Test Kits RDT(Rapid Diagnostic Test) , by Region USD Million (2025-2030)
  • Table 150. IgM/IgG Rapid Test Kits ELISA(Enzyme-linked Immunosorbent Assay) , by Region USD Million (2025-2030)
  • Table 151. IgM/IgG Rapid Test Kits Neutralization Assay , by Region USD Million (2025-2030)
  • Table 152. IgM/IgG Rapid Test Kits: by Application(USD Million)
  • Table 153. IgM/IgG Rapid Test Kits Hospital , by Region USD Million (2025-2030)
  • Table 154. IgM/IgG Rapid Test Kits Special Clinic , by Region USD Million (2025-2030)
  • Table 155. IgM/IgG Rapid Test Kits Research Institution , by Region USD Million (2025-2030)
  • Table 156. IgM/IgG Rapid Test Kits: by Kit Components(USD Million)
  • Table 157. IgM/IgG Rapid Test Kits Detection Cassette , by Region USD Million (2025-2030)
  • Table 158. IgM/IgG Rapid Test Kits Sample Diluent , by Region USD Million (2025-2030)
  • Table 159. IgM/IgG Rapid Test Kits Lancet , by Region USD Million (2025-2030)
  • Table 160. IgM/IgG Rapid Test Kits Bandage , by Region USD Million (2025-2030)
  • Table 161. IgM/IgG Rapid Test Kits Others , by Region USD Million (2025-2030)
  • Table 162. IgM/IgG Rapid Test Kits: by Sample Types(USD Million)
  • Table 163. IgM/IgG Rapid Test Kits Blood , by Region USD Million (2025-2030)
  • Table 164. IgM/IgG Rapid Test Kits Serum , by Region USD Million (2025-2030)
  • Table 165. IgM/IgG Rapid Test Kits Plasma , by Region USD Million (2025-2030)
  • Table 166. IgM/IgG Rapid Test Kits Others , by Region USD Million (2025-2030)
  • Table 167. South America IgM/IgG Rapid Test Kits, by Country USD Million (2025-2030)
  • Table 168. South America IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 169. South America IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 170. South America IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 171. South America IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 172. Brazil IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 173. Brazil IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 174. Brazil IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 175. Brazil IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 176. Argentina IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 177. Argentina IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 178. Argentina IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 179. Argentina IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 180. Rest of South America IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 181. Rest of South America IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 182. Rest of South America IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 183. Rest of South America IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 184. Asia Pacific IgM/IgG Rapid Test Kits, by Country USD Million (2025-2030)
  • Table 185. Asia Pacific IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 186. Asia Pacific IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 187. Asia Pacific IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 188. Asia Pacific IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 189. China IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 190. China IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 191. China IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 192. China IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 193. Japan IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 194. Japan IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 195. Japan IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 196. Japan IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 197. India IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 198. India IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 199. India IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 200. India IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 201. South Korea IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 202. South Korea IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 203. South Korea IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 204. South Korea IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 205. Taiwan IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 206. Taiwan IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 207. Taiwan IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 208. Taiwan IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 209. Australia IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 210. Australia IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 211. Australia IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 212. Australia IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 213. Rest of Asia-Pacific IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 214. Rest of Asia-Pacific IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 215. Rest of Asia-Pacific IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 216. Rest of Asia-Pacific IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 217. Europe IgM/IgG Rapid Test Kits, by Country USD Million (2025-2030)
  • Table 218. Europe IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 219. Europe IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 220. Europe IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 221. Europe IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 222. Germany IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 223. Germany IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 224. Germany IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 225. Germany IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 226. France IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 227. France IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 228. France IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 229. France IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 230. Italy IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 231. Italy IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 232. Italy IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 233. Italy IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 234. United Kingdom IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 235. United Kingdom IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 236. United Kingdom IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 237. United Kingdom IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 238. Netherlands IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 239. Netherlands IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 240. Netherlands IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 241. Netherlands IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 242. Rest of Europe IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 243. Rest of Europe IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 244. Rest of Europe IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 245. Rest of Europe IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 246. MEA IgM/IgG Rapid Test Kits, by Country USD Million (2025-2030)
  • Table 247. MEA IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 248. MEA IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 249. MEA IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 250. MEA IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 251. Middle East IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 252. Middle East IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 253. Middle East IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 254. Middle East IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 255. Africa IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 256. Africa IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 257. Africa IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 258. Africa IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 259. North America IgM/IgG Rapid Test Kits, by Country USD Million (2025-2030)
  • Table 260. North America IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 261. North America IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 262. North America IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 263. North America IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 264. United States IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 265. United States IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 266. United States IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 267. United States IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 268. Canada IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 269. Canada IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 270. Canada IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 271. Canada IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 272. Mexico IgM/IgG Rapid Test Kits, by Type USD Million (2025-2030)
  • Table 273. Mexico IgM/IgG Rapid Test Kits, by Application USD Million (2025-2030)
  • Table 274. Mexico IgM/IgG Rapid Test Kits, by Kit Components USD Million (2025-2030)
  • Table 275. Mexico IgM/IgG Rapid Test Kits, by Sample Types USD Million (2025-2030)
  • Table 276. Research Programs/Design for This Report
  • Table 277. Key Data Information from Secondary Sources
  • Table 278. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global IgM/IgG Rapid Test Kits: by Type USD Million (2018-2023)
  • Figure 5. Global IgM/IgG Rapid Test Kits: by Application USD Million (2018-2023)
  • Figure 6. Global IgM/IgG Rapid Test Kits: by Kit Components USD Million (2018-2023)
  • Figure 7. Global IgM/IgG Rapid Test Kits: by Sample Types USD Million (2018-2023)
  • Figure 8. South America IgM/IgG Rapid Test Kits Share (%), by Country
  • Figure 9. Asia Pacific IgM/IgG Rapid Test Kits Share (%), by Country
  • Figure 10. Europe IgM/IgG Rapid Test Kits Share (%), by Country
  • Figure 11. MEA IgM/IgG Rapid Test Kits Share (%), by Country
  • Figure 12. North America IgM/IgG Rapid Test Kits Share (%), by Country
  • Figure 13. Global IgM/IgG Rapid Test Kits share by Players 2023 (%)
  • Figure 14. Global IgM/IgG Rapid Test Kits share by Players (Top 3) 2023(%)
  • Figure 15. Global IgM/IgG Rapid Test Kits share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Cellex (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Cellex (Germany) Revenue: by Geography 2023
  • Figure 19. RayBiotech (United States) Revenue, Net Income and Gross profit
  • Figure 20. RayBiotech (United States) Revenue: by Geography 2023
  • Figure 21. Biopanda (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Biopanda (United Kingdom) Revenue: by Geography 2023
  • Figure 23. BioMedomics (United States) Revenue, Net Income and Gross profit
  • Figure 24. BioMedomics (United States) Revenue: by Geography 2023
  • Figure 25. GenBody(South Korea) Revenue, Net Income and Gross profit
  • Figure 26. GenBody(South Korea) Revenue: by Geography 2023
  • Figure 27. SD Biosensor(South Korea) Revenue, Net Income and Gross profit
  • Figure 28. SD Biosensor(South Korea) Revenue: by Geography 2023
  • Figure 29. Advaite (United States) Revenue, Net Income and Gross profit
  • Figure 30. Advaite (United States) Revenue: by Geography 2023
  • Figure 31. Premier Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 32. Premier Biotech (United States) Revenue: by Geography 2023
  • Figure 33. Epitope Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 34. Epitope Diagnostics (United States) Revenue: by Geography 2023
  • Figure 35. CTK Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 36. CTK Biotech (United States) Revenue: by Geography 2023
  • Figure 37. Creative Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 38. Creative Diagnostics (United States) Revenue: by Geography 2023
  • Figure 39. Eagle Biosciences (United States) Revenue, Net Income and Gross profit
  • Figure 40. Eagle Biosciences (United States) Revenue: by Geography 2023
  • Figure 41. Sure Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 42. Sure Biotech (United States) Revenue: by Geography 2023
  • Figure 43. SugenTech Inc. (South Korea) Revenue, Net Income and Gross profit
  • Figure 44. SugenTech Inc. (South Korea) Revenue: by Geography 2023
  • Figure 45. Sensing Self, PTE. Ltd (Singapore) Revenue, Net Income and Gross profit
  • Figure 46. Sensing Self, PTE. Ltd (Singapore) Revenue: by Geography 2023
  • Figure 47. Euroimmun AG (Germany) Revenue, Net Income and Gross profit
  • Figure 48. Euroimmun AG (Germany) Revenue: by Geography 2023
  • Figure 49. Liming Bio (China) Revenue, Net Income and Gross profit
  • Figure 50. Liming Bio (China) Revenue: by Geography 2023
  • Figure 51. Beijing Wantai Biological (China) Revenue, Net Income and Gross profit
  • Figure 52. Beijing Wantai Biological (China) Revenue: by Geography 2023
  • Figure 53. Livzon Diagnostics (China) Revenue, Net Income and Gross profit
  • Figure 54. Livzon Diagnostics (China) Revenue: by Geography 2023
  • Figure 55. Global IgM/IgG Rapid Test Kits: by Type USD Million (2025-2030)
  • Figure 56. Global IgM/IgG Rapid Test Kits: by Application USD Million (2025-2030)
  • Figure 57. Global IgM/IgG Rapid Test Kits: by Kit Components USD Million (2025-2030)
  • Figure 58. Global IgM/IgG Rapid Test Kits: by Sample Types USD Million (2025-2030)
  • Figure 59. South America IgM/IgG Rapid Test Kits Share (%), by Country
  • Figure 60. Asia Pacific IgM/IgG Rapid Test Kits Share (%), by Country
  • Figure 61. Europe IgM/IgG Rapid Test Kits Share (%), by Country
  • Figure 62. MEA IgM/IgG Rapid Test Kits Share (%), by Country
  • Figure 63. North America IgM/IgG Rapid Test Kits Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Cellex (Germany)
  • RayBiotech (United States)
  • Biopanda (United Kingdom)
  • BioMedomics (United States)
  • GenBody(South Korea)
  • SD Biosensor(South Korea)
  • Advaite (United States)
  • Premier Biotech (United States)
  • Epitope Diagnostics (United States)
  • CTK Biotech (United States)
  • Creative Diagnostics (United States)
  • Eagle Biosciences (United States)
  • Sure Biotech (United States)
  • SugenTech Inc. (South Korea)
  • Sensing Self, PTE. Ltd (Singapore)
  • Euroimmun AG (Germany)
  • Liming Bio (China)
  • Beijing Wantai Biological (China)
  • Livzon Diagnostics (China)
Additional players considered in the study are as follows:
Shenzhen BioEasy Biotechnology (China) , Orient Gene Biotech (China) , Innovita Biological Technology Co. Ltd. (China) , Dynamiker (Singapore) , Guangzhou Wonfo Biotech (China)
Select User Access Type

Key Highlights of Report


Mar 2024 176 Pages 63 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global IgM/IgG Rapid Test Kits Market Quantitative research analysis
Global IgM/IgG Rapid Test Kits Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

IgM/IgG Rapid Test Kits Market is heading robustly to achieve a new growth cycle.
The Concentration Rate of Global IgM/IgG Rapid Test Kits market is dominated by United States Players and may generate healthy valuation by 2030.
  • Increasing Demand for Corona Test Kits in Hospitals to Diagnose the Patients with Symptoms
  • Increasing Prevalence of Chronic Diseases
  • The Opening of Coronavirus Test Centers at Different Parts of Countries Across the World
dominated the IgM/IgG Rapid Test Kits market. This is attributable to growing trend of "Increasing Number of Investments for Research & Development of IgM/IgG Rapid Test Kits "

Know More About Global IgM/IgG Rapid Test Kits Market Report?

Have a Query? Click Here

Other Related Reports

Disposable Lancets Comprehensive Study by Type (Safety Disposable Lancet, Homecare Disposable Lancet, Others), Application (Cholesterol Tests, Glucose Tests, Others), Distribution Channel (Hospitals,...
$ 3650
Home Rehabilitation Products & Services Comprehensive Study by Type (Positioning Devices, Body Support Devices, General Aids, Wheelchairs), Therapy (Physical Therapy, Occupational Therapy, Speech The...
$ 3500
Diagnostic Guidewire Comprehensive Study by Type (Hydrophilic Diagnostic Guidewires, Hydrophobic Diagnostic Guidewires), Application (Cardiology Applications, Vascular Applications, Neurology Applica...
$ 3750
Dental Block Comprehensive Study by Type (Resin-Based, Zirconia-Reinforced Nano-Ceramic, Hybrid Ceramic), Application (Inlays and Onlays, Dental Crowns, Dental Bridges, Dentures), Translucency Type (...
$ 3750
Aerosol Delivery Devices Comprehensive Study by Type (Small-Volume Nebulize, Pressurized Metered-Dose Inhaler, Dry-Powder Inhaler), Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), ...
$ 3750
Fully-Automatic External Defibrillators Comprehensive Study by Type (Non-synchronous Defibrillator, Synchronous Defibrillator), Application (Hospitals, Public Access, Home, Training, Others), Sales C...
$ 3350